Skip to main navigation
  • About
    • Our Mission
    • Core Values
    • Leadership
    • Partners
  • CRISPR/Cas9
    • What’s CRISPR/Cas9?
    • How CRISPR/Cas9 Works
    • Types of Edits
    • Glossary
  • Programs & Pipelines
    • Full-Spectrum Approach
    • Our Pipeline
    • In Vivo Therapies
    • Ex Vivo Therapies
  • Patients & Families
    • Our Commitment
    • Clinical Trials
    • Community Perspectives & Resources
    • Expanded Access Policy
  • Healthcare Professionals
  • Investors & Media
    • Overview
    • Press Releases
    • Scientific Publications & Presentations
    • Corporate Deck
    • Events & Presentations
    • Press Kit
    • Corporate Governance
    • Financial Info
    • Stock Info
    • Analyst Coverage
    • Investor Resources
  • Careers
    • Life @ Intellia
    • Join Us
  • Full-Spectrum Blog
  • Contact
logo
  • Full-Spectrum Blog
  • Contact
  • About
    • Our Mission
    • Core Values
    • Leadership
    • Partners
  • CRISPR/Cas9
    • What’s CRISPR/Cas9?
    • How CRISPR/Cas9 Works
    • Types of Edits
    • Glossary
  • Programs & Pipelines
    • Full-Spectrum Approach
    • Pipeline
    • In Vivo Therapies
    • Ex Vivo Therapies
  • Patients & Families
    • Our Commitment
    • Clinical Trials
    • Community Perspectives & Resources
    • Expanded Access Policy
  • Healthcare Professionals
  • Investors & Media
    • Overview
    • Press Releases
    • Scientific Publications & Presentations
    • Corporate Deck
    • Events & Presentations
    • Press Kit
    • Corporate Governance
    • Financial Info
    • Stock Info
    • Analyst Coverage
    • Investor Resources
  • Careers
    • Life @ Intellia
    • Join Us
Investors & Media

Events & Presentations

Investor Relations

  • Overview
  • Press Releases
  • Scientific Publications & Presentations
  • Corporate Deck
  • Events & Presentations
  • Press Kit
  • Corporate Governance
  • Financial Info
  • Stock Info
  • Analyst Coverage
  • Investor Resources

Events and Presentations

  • Upcoming Events
  • Past Events
  • Presentations
  • ESG Report
All Past Events
2022
2021
2020
May 5, 2022 8:00 AM EDT
Intellia Therapeutics First Quarter 2022 Earnings Conference Call

US dial-in: 1-833-316-0545
International dial-in: 1-412-317-5726
All participants should ask to be connected to the Intellia Therapeutics conference call.

Click Here for Webcast
Mar 15, 2022 9:00 AM EDT
Barclays Global Healthcare Conference
Miami, Florida
Click Here for Webcast
Feb 28, 2022 4:30 PM EST
Intellia Therapeutics Call to Discuss Interim Clinical Data from NTLA-2001 Phase 1 Study
Click here for webcast

Supporting Materials

NTLA-2001 for ATTR Amyloidosis: Interim Clinical Results from Ongoing Phase 1 Trial 1.4 MB
Feb 24, 2022 8:00 AM EST
Intellia Therapeutics Fourth Quarter and Full-Year 2021 Earnings Conference Call

US dial-in: 1-833-316-0545
International dial-in: 1-412-317-5726
All participants should ask to be connected to the Intellia Therapeutics conference call.

Click here for a simultaneous live webcast of the call and replay
Jan 12, 2022 2:15 PM EST
40th Annual J.P. Morgan Healthcare Conference

Virtual

Click Here for Webcast

Supporting Materials

J.P. Morgan Healthcare Conference Presentation 1.3 MB
Contact IR Contact IR
Email Alerts
RSS Feeds
RSS Feeds
Print Page

Footer Links

  • Cookie Policy
  • Terms of Use
  • Privacy Policy

© Intellia Therapeutics, Inc. 2022

Intellia Therapeutics and the Intellia Therapeutics logo are registered trademarks with the U.S. Patent & Trademark Office.